What is the appropriate management for a 69-year-old male with hypercalcemia (adjusted calcium 12.3 mg/dL), Helicobacter pylori infection, who is currently on testosterone therapy and lisinopril?

Management of Hypercalcemia in a 69-Year-Old Male

This patient requires immediate workup to determine the etiology of moderate hypercalcemia (12.3 mg/dL), with urgent discontinuation of testosterone therapy and measurement of intact PTH to guide definitive treatment.

Immediate Actions

1. Discontinue Testosterone

Testosterone therapy can cause hypercalcemia, particularly in immobilized patients, and must be stopped immediately 1. The FDA label explicitly warns that hypercalcemia may occur with androgen therapy and requires drug discontinuation when identified 1.

2. Assess Lisinopril Contribution

While lisinopril itself doesn't directly cause hypercalcemia, ACE inhibitors can worsen renal function and complicate calcium homeostasis 2. Monitor renal function closely, as the combination of hypercalcemia and potential ACE inhibitor-related renal impairment creates additional risk 2.

Diagnostic Algorithm

Step 1: Measure Intact PTH (Most Critical Test)

• If PTH elevated or inappropriately normal: Primary hyperparathyroidism is the diagnosis 3
• If PTH suppressed (<20 pg/mL): Consider malignancy, granulomatous disease, endocrinopathies (including adrenal insufficiency), or medication effects 3

This single test distinguishes PTH-dependent from PTH-independent causes and directs all subsequent management 3.

Step 2: Additional Workup Based on PTH Result

If PTH-independent (suppressed PTH):

• Screen for malignancy (most common cause after hyperparathyroidism) 3
• Check 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels
• Consider PTHrP if malignancy suspected
• Evaluate for adrenal insufficiency (cortisol, ACTH) - this is particularly important as it can present with hypercalcemia and is easily treatable 4
• Chest imaging for granulomatous disease

If PTH-dependent (elevated PTH):

• Parathyroid imaging (ultrasound, sestamibi scan)
• Assess for surgical candidacy

Treatment Strategy

For Moderate Hypercalcemia (12.3 mg/dL)

Initial Management:

• Aggressive IV hydration with normal saline - cornerstone of acute therapy 3, 5
• Monitor for fluid overload given lisinopril use and potential underlying cardiac/renal disease 2
• Loop diuretics only if volume overload develops (not routinely) 5

Definitive Treatment Based on Etiology

If Primary Hyperparathyroidism:

• Parathyroidectomy is curative for symptomatic disease or if patient meets surgical criteria 3
• Observation acceptable if: age >50 years, calcium <1 mg/dL above upper limit, no skeletal/renal involvement 3

If Malignancy-Related:

• IV bisphosphonate (zoledronic acid or pamidronate) is first-line 6, 3
• Denosumab is suggested over bisphosphonates for hypercalcemia of malignancy 6
• Calcitonin NOT needed at this calcium level (reserved for severe hypercalcemia >14 mg/dL) 6
• Treat underlying malignancy

If Adrenal Insufficiency:

• IV glucocorticoids produce rapid improvement 4
• This diagnosis must not be missed as it is immediately life-threatening and easily treatable

If Granulomatous Disease:

• Glucocorticoids are primary treatment for excessive intestinal calcium absorption 3

H. Pylori Management

The H. pylori infection is a separate issue requiring treatment but does not contribute to hypercalcemia 7. Treat according to current guidelines with appropriate eradication therapy after addressing the acute hypercalcemia 8, 9. Consider antimicrobial susceptibility testing given rising resistance rates 8.

Critical Pitfalls to Avoid

1. Do not assume malignancy without PTH testing - 90% of hypercalcemia is either hyperparathyroidism or malignancy, and PTH immediately distinguishes them 3, 5

2. Do not overlook adrenal insufficiency - this treatable cause presents with hypercalcemia and can be fatal if missed 4

3. Do not continue testosterone - this is a known cause and must be stopped 1

4. Do not use loop diuretics routinely - only if volume overload occurs 5

5. Do not delay bisphosphonates if malignancy confirmed - these provide long-term control while addressing underlying cancer 6, 10

Prognosis

• Asymptomatic primary hyperparathyroidism: Excellent prognosis with either surgical or medical management 3
• Hypercalcemia of malignancy: Associated with poor survival, requires aggressive treatment of underlying cancer 3
• Medication-induced (testosterone): Should resolve with drug discontinuation